Living with diabetic polyneuropathy can be an uphill battle, marked by persistent pain and challenges in motor nerve function. However, a recent study conducted by Vinay Graak, Sarika Chaudhary, B. S. Bal, and J. S. Sandhu sheds light on a potential game-changer in managing this condition – pulsed electromagnetic field (PEMF) therapy. This randomized controlled trial, performed at Guru Nanak Dev University and Medical College in Amritsar, India, explores the impact of low-power, low-frequency PEMF at 600 and 800 Hz in alleviating diabetic polyneuropathy symptoms.

The study's primary aim was to evaluate and compare the effectiveness of low-frequency PEMF in managing diabetic polyneuropathy. The research employed a randomized controlled trial with a different subject experimental design, ensuring a comprehensive assessment of the therapy's impact. Thirty subjects, aged 40–68 years, diagnosed with diabetic polyneuropathy stages N1a, N1b, N2a, were randomly assigned to three groups: Group 1 received 600-Hz PEMF, Group 2 received 800-Hz PEMF, and Group 3 (control) underwent usual medical treatment for diabetic polyneuropathy.

The subjects underwent 30-minute PEMF sessions for 12 consecutive days. Pain and motor nerve conduction parameters were assessed before and after treatment, including distal latency, amplitude, and nerve conduction velocity. Statistical analysis, involving related t-tests and unrelated t-tests, was utilized to analyze the gathered data.

The study yielded significant findings, providing hope for those grappling with diabetic polyneuropathy. Both experimental groups, receiving 600-Hz and 800-Hz PEMF, experienced a substantial reduction in pain. Moreover, a statistically significant improvement (P<0.05) in distal latency and nerve conduction velocity was observed in these groups.

The study's conclusions are both promising and revolutionary. Low-frequency PEMF emerges as a potential adjunct therapy, offering relief from neuropathic pain and slowing down the progression of neuropathy in a relatively short period. These results open doors to new possibilities in the realm of diabetic polyneuropathy management, providing a glimmer of hope for those seeking effective and efficient solutions to alleviate their symptoms.

Reference: https://electromeds.com/wp-content/uploads/2020/05/diabetic-polyneuropathy.pdf